Ledger.Open graph →
SEC Form D · filed June 16, 2022

Voltron Therapeutics, Inc

Offering
$5.0M
Sold
$300K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James Ahern · New York, NYDirectorAnthony Zook · New York, NYDirectorMatthew Duffy · New York, NYExec · DirectorMatthew Eitner · New York, NYDirectorPaul Korner · New York, NYDirectorPatrick Gallagher · New York, NYExec · DirectorAneek Mamik · Minneapolis, MNDirectorIlfryn Carstairs · Minneapolis, MNExec · DirectorMarcia Page · Minneapolis, MNDirectorBradley Bauer · Minneapolis, MNDirectorHaseeb Malik · Minneapolis, MNExec · DirectorTimothy Mooney · Minneapolis, MNDirectorGeorge M. Ager, Jr · Southampton, PADirectorRobert T. Strong · Southampton, PADirectorJames J. Clarke · Southampton, PAExec · DirectorJohn J. Augustine · Southampton, PADirectorAndrew E. Dipiero, Jr · Southampton, PADirectorKenneth R. Gant · Southampton, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗